K
Market Data
$11.80+$1.87 (+18.83%)
KROS · Last trade
Prev Close
$9.93
Range (29d)
$10.03 – $12.03
Recent Filings
- 8-K178.1 KBKeros Therapeutics, Inc.Jun 25, 4:02 PM ET·0001664710-26-000036
- 8-K162.4 KBKeros Therapeutics, Inc.Jun 3, 4:01 PM ET·0001664710-26-000034
- 8-K162.4 KBKeros Therapeutics, Inc.Jun 1, 4:02 PM ET·0001664710-26-000032
- 10-Q5.3 MBKeros Therapeutics, Inc.May 14, 8:02 AM ET·0001664710-26-000030
- 8-K241.1 KBKeros Therapeutics, Inc.May 14, 8:01 AM ET·0001664710-26-000029
- 8-K238.6 KBKeros Therapeutics, Inc.Mar 9, 8:01 AM ET·0001664710-26-000024
- 8-K4.6 MBKeros Therapeutics, Inc.Mar 4, 4:08 PM ET·0001664710-26-000021
- 10-K13.5 MBKeros Therapeutics, Inc.Mar 4, 4:04 PM ET·0001664710-26-000018
- 8-K319.3 KBKeros Therapeutics, Inc.Mar 4, 4:02 PM ET·0001664710-26-000017
- 8-K232.9 KBKeros Therapeutics, Inc.Feb 26, 4:02 PM ET·0001664710-26-000008
Insiders
10- ADAR1 Capital Management, LLC10% Owner
- ADAR1 Partners, LP10% Owner
- Arkin Bio Ventures Limited Partnership10% Owner
- Arkin Moshe10% Owner
- BIENAIME JEAN JACQUESDirector
- CHYUNG YUNG H.Chief Medical Officer
- Cho EstherChief Legal Officer
- Cooper Simon PeterChief Medical Officer
- Farzan NimaDirector
- GORDON CARL LDirector
Tickers
Addresses
business
1050 WALTHAM STREET, SUITE 302
LEXINGTON, MA, 02421
mailing
1050 WALTHAM STREET, SUITE 302
LEXINGTON, MA, 02421